PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
NR2E3 |
Q9Y5X4
|
nuclear receptor subfamily 2 group E member 3
|
Nuclear receptor
|
|
0.603 |
0.500 |
PCAT1 |
|
prostate cancer associated transcript 1
|
|
|
0.575 |
0.615 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
NPHP3-ACAD11 |
|
NPHP3-ACAD11 readthrough (NMD candidate)
|
|
|
0.663 |
0.577 |
ZFAS1 |
|
ZNFX1 antisense RNA 1
|
|
|
0.582 |
0.615 |
HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
SOX2-OT |
|
SOX2 overlapping transcript
|
|
|
0.597 |
0.615 |
IGF2-AS |
Q6U949
|
IGF2 antisense RNA
|
|
|
0.612 |
0.615 |
TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
LUCAT1 |
|
lung cancer associated transcript 1
|
|
|
0.612 |
0.577 |
CCDC26 |
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
|
0.647 |
0.615 |
SNHG7 |
|
small nucleolar RNA host gene 7
|
|
|
0.619 |
0.500 |
DLEU2 |
|
deleted in lymphocytic leukemia 2
|
|
|
0.650 |
0.500 |
DLX6-AS1 |
|
DLX6 antisense RNA 1
|
|
|
0.628 |
0.423 |
CASC9 |
|
cancer susceptibility 9
|
|
|
0.644 |
0.462 |
SNHG15 |
|
small nucleolar RNA host gene 15
|
|
|
0.633 |
0.615 |
FALEC |
|
focally amplified long non-coding RNA in epithelial cancer
|
|
|
0.644 |
0.423 |
COMETT |
|
cytosolic oncogenic antisense to MET transcript
|
|
|
0.678 |
0.538 |
ACTN3 |
Q08043
|
actinin alpha 3 (gene/pseudogene)
|
|
|
0.663 |
0.500 |
HELLPAR |
|
HELLP associated long non-coding RNA
|
|
|
0.760 |
0.269 |
MIR100HG |
|
mir-100-let-7a-2-mir-125b-1 cluster host gene
|
|
|
0.682 |
0.308 |